Search    ENTER KEYWORD
MSDS Material Safety Data Sheet
CAS

N/A

File Name: hhs_gov---medicarefundingwarningsummary.asp
                  Medicare Funding Warning Response Act of 2008

Summary

NOTE: Except as otherwise indicated, references in this summary are to the Social
Security Act. Terms used in this summary have the following meanings:

鈥? The "Secretary" means the Secretary of Health and Human Services.

鈥? "Medicare" and "Medicare program" mean the program under title XVIII of the
Social Security Act.

鈥? "CMS" means the Centers for Medicare & Medicaid Services.

鈥? "MMA" means The Medicare Prescription Drug, Improvement, and
Modernization Act of 2003 (P.L. 108-173).

鈥? "Medicare funding warning" has the meaning given such term by section
801(a)(2) of the MMA.

鈥? "Excess general revenue medicare funding" has the meaning given such term by
section 801(c) of the MMA (and "excess funding" has the same meaning).

SECTION 1. SHORT TITLE; REFERENCES; PURPOSE OF LEGISLATION.

Subsection (a) provides that the Act may be cited as the "Medicare Funding Warning
Response Act of 2008". Subsection (b) provides an explanation of various references
used in the Act. Subsection (c) states that the purpose of the Act is to respond to the
medicare funding warning currently in effect under section 801(a)(2) of the MMA.

TITLE I鈳疘NTRODUCING PRINCIPLES OF VALUE-BASED HEALTH CARE
INTO THE MEDICARE PROGRAM

SEC. 101. INTRODUCING PRINCIPLES OF VALUE-BASED HEALTH CARE
INTO THE MEDICARE PROGRAM.

Subsection (a) requires the Secretary to develop and implement a system for encouraging
nationwide adoption and use of interoperable electronic health records and to make
personal health records available to Medicare beneficiaries.

Subsection (b) requires the Secretary to provide price and cost information (including
information related to episodes of care) to Medicare beneficiaries to assist them in
making choices among providers, plans, and treatment options.
2


Subsection (c) requires the Secretary to provide quality of care information to Medicare
beneficiaries to assist them in making choices among providers, plans, and treatment
options. In addition, the Secretary is required to develop a plan for ensuring that by
2013, quality measures are available and reported with respect to at least 50 percent of
the care provided under the Medicare program, and to report annually to the Congress on
progress with respect to these goals.

Subsection (d) directs the Secretary to:

鈥? Design and implement a system under which a portion of the payment that would
otherwise be made to individuals or entities serving Medicare beneficiaries is
based on the quality and efficiency of their performance. The Secretary would be
required to first implement such system in settings where measures are well-
accepted and already collected. The system would also include incentives for
reducing unwarranted geographic variation in quality and efficiency.

鈥? Implement incentives for Medicare beneficiaries to use more efficient providers
and preventive services known to reduce costs, and assure a transition into the
Medicare program for individuals who own health savings accounts.

Subsection (e) requires the Secretary to use and release Medicare data for quality
improvement, performance measurement, public reporting, and treatment-related
purposes.

Subsection (f) requires the Secretary to ensure that individually identifiable beneficiary
health information is appropriately protected.

Subsection (g) authorizes the Secretary to implement any of the systems described in
section 101 through regulation, but only if the Secretary provides for public notice and an
opportunity for public comment with respect to such regulation.

Subsection (h) provides definitions of the terms "efficiency" and "information on quality
of care".

Subsection (i) provides that the Secretary may implement the provisions of subsections
(a) through (e) of section 101 and section 102 for a year only to the extent that the
Secretary determines (and the Chief Actuary of the Centers for Medicare & Medicaid
Services certifies) that:

鈥? The total amount of payment made under Medicare over the five and ten year
periods that begin with January 1 of such year as a result of the implementation of
such provisions is less than the amount that would have been made over such
periods if such provisions had not been implemented.
3


鈥? The total amount of payment made under each of Medicaid and SCHIP over those
same time periods is no greater than the amount that would have been made if
such provisions had not been implemented.

SEC. 102. RELEASE OF PHYSICIAN PERFORMANCE MEASUREMENTS.

Section 102 amends section 1848(k) to add a new paragraph (9), authorizing the
Secretary to publicly release physician-specific measurements of the quality or efficiency
of physician performance (against a standard endorsed by the Secretary pursuant to a
notice in the Federal Register). The Secretary is also authorized to release necessary data
to an entity responsible for generating or calculating such measurements. Proposed
section 1848(k)(9) provides that the Secretary may make such releases notwithstanding
the provisions of the Privacy Act (section 552a of title 5, United States Code).

TITLE II鈳疪EDUCING THE EXCESSIVE BURDEN THE LIABILITY SYSTEM
PLACES ON THE HEALTH CARE DELIVERY SYSTEM

SEC. 201. SHORT TITLE.

Section 201 provides that title II may be cited as the "Help, Efficient, Accessible, Low-
cost, Timely Healthcare (HEALTH) Act of 2008".

SEC. 202. FINDINGS AND PURPOSE.

Section 202 states the findings and purpose of the title.

SEC. 203. ENCOURAGING SPEEDY RESOLUTION OF CLAIMS.

Section 203 establishes a statute of limitations of three years after the date of
manifestation of injury or one year after the claimant discovers (or should have
discovered) the injury, whichever comes first, unless tolled on the basis of fraud,
intentional concealment, or the presence of a foreign body in the injured person. This
section also provides that lawsuits on behalf of minors under the age of six years must be
commenced within three years of the manifestation of the injury or prior to their eighth
birthday, whichever provides the longer period, with certain exceptions.

SEC. 204. COMPENSATING PATIENT INJURY.

Section 204 establishes rules concerning patients' ability to recover for certain types of
damages. Included in section 204 are provisions:

鈥? Declaring that, with respect to any health care lawsuit, nothing in title II limits the
recovery of economic damages.

鈥? Limiting noneconomic damages for the same injury to $250,000, and prohibiting
the jury from being informed of such limit.
4




鈥? Making each party liable only for the amount of damages directly proportional to
such party's percentage of responsibility.

SEC. 205. MAXIMIZING PATIENT RECOVERY.

Section 205 requires court supervision over payment arrangements to protect against
conflicts of interest that may reduce the amount of damages awarded that are actually
paid to claimants. Section 205 authorizes courts to restrict the payment of attorney
contingency fees, and provides that the total of all contingency fees for representing all
claimants in a health care lawsuit may not exceed: (1) 40 percent of the first $50,000
recovered by the claimant(s); (2) 33 1/3 percent of the next $50,000; (3) 25 percent of the
next $500,000; and (4) 15 percent of any amount recovered in excess of $600,000.

SEC. 206. ADDITIONAL HEALTH BENEFITS.

Section 206 permits any party to a lawsuit involving injury or wrongful death to
introduce evidence of collateral source benefits; and any opposing party to then introduce
evidence of any amount paid or contributed to secure the right to such benefits. Under
this section, providers of such benefits are prohibited from recovering any amount from
the claimant's recovery or from being subrogated to the right of the claimant. The
provisions of section 206 do not apply to the Medicare secondary payer provisions of
section 1862(b) of the Social Security Act or to the Medicaid third party liability
provisions of section 1902(a)(25) of such Act, to specified provisions of the Federal
Employees' Compensation Act, or to employee benefit plans subject to Title I of the
Employee Retirement Income Security Act.

SEC. 207. PUNITIVE DAMAGES.

Section 207 specifies new guidelines for the awarding of punitive damages. Under this
section, punitive damages may be awarded (if otherwise permitted by applicable State or
Federal law) against a person in a health care lawsuit only if: (1) the claimant proves by
clear and convincing evidence that the person acted with malicious intent to injure the
claimant, or that such person deliberately failed to avoid unnecessary injury that such
person knew the claimant was substantially certain to suffer; and (2) compensatory
damages are awarded. This section also establishes procedural requirements for a claim
for punitive damages, and enumerates the factors to be considered for an award of
punitive damages, including: the severity of harm caused by the conduct of the party; the
duration of the conduct or any concealment of it; the profitability of the conduct; and any
criminal penalties imposed. Under section 207, punitive damage awards are limited to
the greater of $250,000 or two times the amount of economic damages awarded, and the
jury may not be informed of such limit.

Section 207 also prohibits a punitive damage award in a product liability suit against a
manufacturer, distributor, or supplier of a medical product that has been approved by the
Food and Drug Administration (FDA) or that is generally recognized among qualified
5


experts as safe and effective pursuant to conditions established by the FDA. Section 207
provides exceptions if: (1) the trier of fact finds by clear and convincing evidence that
the product is substantially out of compliance with applicable labeling or packaging
regulations; (2) a person knowingly misrepresented or withheld from the FDA required
information that is material and causally related to the harm suffered by the claimant; or
(3) an illegal payment is made to an FDA official to secure approval of the medical
product. In addition, section 207 prohibits a product liability suit against a medical care
provider who prescribes or dispenses such a medical product approved by the FDA.

SEC. 208. AUTHORIZATION OF PAYMENT OF FUTURE DAMAGES TO
CLAIMANTS IN HEALTH CARE LAWSUITS.

Section 208 requires the court, at the request of any party, to order that the award of
future damages equaling or exceeding $50,000 be paid by periodic payments.

SEC. 209. DEFINITIONS.

Section 209 provides definitions for terms used in title II.

SEC. 210. EFFECT ON OTHER LAWS.

Section 210 declares that title II does not apply to civil actions brought for a vaccine-
related injury or death which is covered under provisions of the Public Health Service
Act. In addition, section 210 states that nothing in title II should affect any defense
available to a defendant in a health care lawsuit or action under any other provision of
Federal law.

SEC. 211. STATE FLEXIBILITY AND PROTECTION OF STATES' RIGHTS.

Section 211 specifies rules governing the relationship between the provisions of title II
and State and Federal laws. Section 211 provides that title II preempts State law to the
extent that it prevents the application of any provision of law established by the Act, but
does not: (1) preempt State law that provides greater protections for health care providers
or organizations or that specifies particular damage limits; or (2) affect any defenses
available to a party under any other provision of State or Federal law.

Section 211 also provides that title II supersedes the Federal Tort Claims Act (FTCA) to
the extent that the FTCA would provide for (or allow for) a greater amount of damages or
contingent fees or a longer period in which a health care lawsuit may be commenced, or
would preclude or reduce the applicability of title II's provisions related to periodic
payments of future damages. The FTCA is also superseded if (through the application of
State law) it conflicts with provisions of title II concerning joint liability, collateral source
benefits, subrogation, or liens.

SEC. 212. APPLICABILITY; EFFECTIVE DATE.
6


Section 212 states that the provisions of title II apply to any health care lawsuit brought in
Federal or State court, or subject to alternative dispute resolutions system, that is initiated
on or after the date of the enactment of the title, except that any health care lawsuit
arising from an injury occurring prior to the date of the enactment of the title is governed
by the applicable statute of limitations provisions in effect at the time the injury occurred.

TITLE III鈳疘NCREASING HIGH-INCOME BENEFICIARY AWARENESS AND
RESPONSIBILITY FOR HEALTH CARE COSTS

SEC. 301. INCOME-RELATED REDUCTION IN PART D PREMIUM SUBSIDY.

Section 301 amends section 1860D-13(a) of the Social Security Act to add a new
paragraph (7) (Reduction in Premium Subsidy Based on Income) to extend the Medicare
Part B income-related premium adjustment to the Part D program (with certain
differences). Under current law, the Federal government provides a subsidy for the cost
of Part D prescription drug coverage. Effective January 1, 2009, proposed section
1860D-13(a)(7) would reduce the Federal subsidy and increase the beneficiary premium
for prescription drug coverage for single beneficiaries with incomes greater than $82,000
and married beneficiaries with incomes greater than $164,000. Unlike the beneficiary
income thresholds that apply with respect to the parallel process for premium adjustments
under Part B, the beneficiary income thresholds used for purposes of the Part D premium
calculations would hold constant as fixed dollar amounts without any indexing.

Under proposed section 1860D-13(a)(7), the additional payment amount owed by an
individual whose Part D premium is subject to adjustment would be collected through
withholding from benefit payments in the manner provided under section 1840 of the
Social Security Act (and the proposed section establishes a procedure in the event such
benefit payments are not sufficient to pay the premium adjustment amount). Proposed
section 1860D-13(a)(7) establishes procedures for ensuring that the income-related
premium adjustments required by the proposed section will be carried out correctly. The
section also includes conforming amendments to title XVIII of the Social Security Act
and to the Internal Revenue Code of 1986.

Search    ENTER KEYWORD
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
head-start_lane_or_us---Isopropyl_Alcohol.asp 67-63-0
head-start_lane_or_us---Ivory_Liquid_Dish_Detergent.asp 64-17-5
head-start_lane_or_us---Joy_Liquid_Dishwashing_Detergent.asp 64-17-5
head-start_lane_or_us---Meltaway_Ice_Melting_Compound.asp N/A
head-start_lane_or_us---Mineral_Oil.asp N/A
head-start_lane_or_us---Murphy_Oil_Soap_Liquid.asp N/A
head-start_lane_or_us---Murphy_Oil_Soap_Spray.asp N/A
head-start_lane_or_us---Nail_Polish_Remover.asp 84-74-2 123-86-4 67-64-1
head-start_lane_or_us---Palmers_Washable_Dry_Tempera.asp 1317-65-3 9004-53-9 7727-43-7 532-32-1 9084-06-4
head-start_lane_or_us---Plaster_of_Paris.asp 1317-65-3 7778-18-9 14808-60-7
head-start_lane_or_us---Puritan_Delimer.asp N/A
head-start_lane_or_us---Puritan_Machine_Bar_Detergent.asp 1310-73-2 37971-36-1
head-start_lane_or_us---Quintet_Chlorine_Sanitizer.asp 1677-52-5 7681-52-9
head-start_lane_or_us---Quintet_P.asp 7758-29-4 497-19-8 1344-09-8 51580-86-0
head-start_lane_or_us---Quintet_R.asp 1300-72-7
head-start_lane_or_us---Renown_Pink.asp 68603-42-9 68585-47-7
head-start_lane_or_us---Roach_Powder_16oz.asp 10043-35-3
head-start_lane_or_us---Ross_Glitter_Colors.asp N/A
head-start_lane_or_us---Ross_Rubber_Cement.asp 142-82-5 67-63-0
head-start_lane_or_us---Ross_Rubber_Cement_BCPJP.asp 110-54-3
head-start_lane_or_us---Ross_White_Glue.asp N/A
head-start_lane_or_us---SPEEDBALL_2000_Power_Cleaner_Ready-to-Use.asp 141-43-5
head-start_lane_or_us---Starch_Corn.asp 9005-25-8
head-start_lane_or_us---Xylol.asp N/A
healthlinkinc_net---ChlorazolBlackE.asp 67-68-5 1310-58-3 1937-37-7
healthlinkinc_net---CTech6.asp N/A
healthlinkinc_net---PotassiumHydroxide20in30DMSO.asp 1310-58-3 67-68-5
healthycanadians_gc_ca---Cons_ActionPlan_Paper_eng_06.asp N/A
hemagen_com---MSDS-VET-16.asp 1135-40-6 9002-93-1 99-20-7 25322-68-3 13059-60-4 328-50-7 77-86-1 7365-45-9 13746-66-2 2044-56-6 7758-99-8 1310-73-2
hernonmfg_com---ms-371.asp N/A
heroglobal_net---Msds-Zycoprime.asp N/A
heroglobal_net---MSDS-Zycosil.asp N/A
hhs_gov---medicarefundingwarninglegislation.asp N/A
hhs_gov---medicarefundingwarningsummary.asp N/A
hillbrothers_com---cmfps-pigmented.asp 25265-77-4 57-55-6
hillbrothers_com---db-rts-300-2.asp 107-21-1 111-76-2
hillbrothers_com---dc-base.asp 14808-60-7 65997-15-1
hillbrothers_com---hydrochloric-acid.asp 7647-01-0
hillbrothers_com---sodium-fluoride.asp 7681-49-4
hillyard_com---MSDSHIL00496.asp 7732-18-5 770-35-4
hollisterwoundcare_com---529975-529976.asp N/A
homecare_noveon_com---HMC-0005.asp N/A
hoppes_com---M-Pro7CleanerLubricantProtectantMSDS.asp 66070-54-0 16958-92-2
hp_com---07_hp_material_timeline.asp N/A
hp_com---dfe_lifecycle_07.asp N/A
hp_com---energystar_computer1101.asp N/A
hp_com---energystar_monitors.asp N/A
hp_com---energystar_printers1101.asp N/A
hp_com---gse.asp N/A
hp_com---koeco.asp N/A

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com | Ads link:HBCCHEM.INC